"breast cancer survival" trang 5 - tải miễn phí từ tailieunhanh
Integration of breast cancer care in a middleincome country: Learning from Suandok Breast Cancer Network (SBCN)

Integration of breast cancer care in a middleincome country: Learning from Suandok Breast Cancer Network (SBCN)
7    49    3
Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers
11    46    1
Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients

Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
12    69    1
Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital - a closer look into cause-specific mortality

Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital - a closer look into cause-specific mortality
10    51    1
Clinical features and survival of pregnancyassociated breast cancer: A retrospective study of 203 cases in China

Clinical features and survival of pregnancyassociated breast cancer: A retrospective study of 203 cases in China
8    78    0
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
11    66    0
Worse survival in breast cancer in elderly may not be due to underutilization of medical procedures as observed upon changing healthcare system in Poland

Worse survival in breast cancer in elderly may not be due to underutilization of medical procedures as observed upon changing healthcare system in Poland
7    82    0
High baseline Tie1 level predicts poor survival in metastatic breast cancer

High baseline Tie1 level predicts poor survival in metastatic breast cancer
10    78    0
BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer

BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer
11    74    0
Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
9    49    0
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: A retrospective study

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: A retrospective study
11    60    0
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data
7    77    0
Ethnic disparities in breast cancer survival in New Zealand: Which factors contribute

Ethnic disparities in breast cancer survival in New Zealand: Which factors contribute
10    67    1
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
11    68    1
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival

PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
8    69    1
Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial
6    60    1
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
9    44    1
Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers

Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers
8    53    1
Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?

Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?
9    45    1
Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index
12    80    1